Extension Study to Assess Tolerability and Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients Who Received Mycophenolate Mofetil

Status:
Completed

Trial end date:
2005-04-01

Target enrollment:

Participant gender:

This extension study is considered to allow patients being treated with EC-MPS to collect further information on the long-term safety of this drug.

Phase 4

Novartis

Mycophenolate mofetil
Mycophenolic Acid